FLUIDIA Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $197K
Latest Deal Amount

FLUIDIA General Information


Developer of multi-protein diagnostic tests designed to be used for the early diagnosis of human diseases. The company's tests include immunoenzymatic test that allows the quantitative assay of the whole and phosphorylated form of Raf Kinase Inhibitor Protein in any biological sample, enabling pathologists and biologists to develop new technological methods for precision medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Policlinico di Bari
  • Piazza Giulio Cesare, 11
  • 71124 Bari
  • Italy
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FLUIDIA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Equity Crowdfunding 23-Jun-2018 $197K 00.000 Completed Generating Revenue
To view FLUIDIA’s complete valuation and funding history, request access »

FLUIDIA Executive Team (3)

Name Title Board Seat Contact Info
Nicola Marino Chief Operating Officer
Elena Ranieri Ph.D Co-Founder
Massimo Papale Ph.D Co-Founder
To view FLUIDIA’s complete executive team members history, request access »